Intravenous drug
Intravenous drug is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation
Effects of Antiemetic Agents in Orthognathic Surgery Patients
Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur
IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
Comparing the Effects of Ondansetron Versus Dexamethasone on the Incidence of Post-dural Puncture Headache (PDPH) , Nausea and Vomiting After Spinal Anaesthesia of Parturients Undergoing Caesarean Section
Clinical Trials (6)
Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation
Effects of Antiemetic Agents in Orthognathic Surgery Patients
Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur
IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
Comparing the Effects of Ondansetron Versus Dexamethasone on the Incidence of Post-dural Puncture Headache (PDPH) , Nausea and Vomiting After Spinal Anaesthesia of Parturients Undergoing Caesarean Section
Sevoflurane in COVID-19 ARDS (SevCov)
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6